Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Cisplatin is a platinum-based chemotherapeutic drug for treating various types of cancers. However, the use of cisplatin is limited by its negative effect on normal tissues, particularly nephrotoxicity. Various mechanisms such as DNA adduct formation, mitochondrial dysfunction, oxidative stress, and apoptosis are involved in the adverse effect induced by cisplatin treatment. Several studies have suggested that neuropeptide Y (NPY) is involved in neuroprotection as well as restoration of bone marrow dysfunction from chemotherapy induced nerve injury. However, the role of NPY in chemotherapy- induced nephrotoxicity has not been studied. Here, we show that NPY rescues renal dysfunction by reducing the expression of pro-apoptotic proteins in cisplatin induced nephrotoxicity through Y1 receptor, suggesting that NPY can protect kidney against cisplatin nephrotoxicity as a possible useful agent to prevent and treat cisplatin-induced nephrotoxicity.
Abstract
Cisplatin is a platinum-based chemotherapeutic drug for treating various types of cancers. However, the use of cisplatin is limited by its negative effect on normal tissues, particularly nephrotoxicity. Various mechanisms such as DNA adduct formation, mitochondrial dysfunction, oxidative stress, and apoptosis are involved in the adverse effect induced by cisplatin treatment. Several studies have suggested that neuropeptide Y (NPY) is involved in neuroprotection as well as restoration of bone marrow dysfunction from chemotherapy induced nerve injury. However, the role of NPY in chemotherapy- induced nephrotoxicity has not been studied. Here, we show that NPY rescues renal dysfunction by reducing the expression of pro-apoptotic proteins in cisplatin induced nephrotoxicity through Y1 receptor, suggesting that NPY can protect kidney against cisplatin nephrotoxicity as a possible useful agent to prevent and treat cisplatin-induced nephrotoxicity.
참고문헌 (21)
- Pabla N, "Cisplatin nephrotoxicity: mechanisms and renoprotective strategies", Kidney Int, 73, pp.994~1007 (2008)
- Siddik ZH, "Cisplatin : mode of cytotoxic action, molecular basis of resistance", Oncogene, 22, pp.7265~7279 (2003)
- Pabla N, "Inhibition of PKCreduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer", J Clin Invest, 121, pp.2709~2722 (2011)
- Jia Z, "Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis", Kidney Int, 79, pp.77~88 (2011)
- Oh GS, "Pharmacological activation of NQO1 increases NAD＋ levels, attenuates cisplatin-mediated acute kidney injury in mice", Kidney Int, 85, pp.547~560 (2014)
- Sah R, "Neuropeptide Y, posttraumatic stress disorder", Mol Psychiatry, 18, pp.646~655 (2013)
- Santos-Carvalho A, "Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic, apoptotic cell death induced by glutamate", Cell Death Dis, 4, pp.e636~ (2013)
- Körner M, "Neuropeptide Y receptor expression in human primary ovarian neoplasms", Lab Invest, 84, pp.71~80 (2004)
- Gonçalves J, "Protective role of neuropeptide Y Y2 receptors in cell death, microglial response following methamphetamine injury", Eur J Neurosci, 36, pp.3173~3183 (2012)
- Park MH, "Neuropeptide Y regulates the hematopoietic stem cell microenvironment, prevents nerve injury in the bone marrow", EMBO J, 34, pp.1648~1660 (2015)
- Humanes B, "Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats", Kidney Int, 82, pp.652~663 (2012)
- Panesso MC, "Klotho has dual protective effects on cisplatin-induced acute kidney injury", Kidney Int, 85, pp.855~870 (2014)
- Linkermann A, "Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure", Kidney Int, 79, pp.169~178 (2011)
- Jiang M, "Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity", Am J Physiol Renal Physiol, 287, pp.F1140~F1147 (2004)
- Xu Y, "A Role for Tubular Necroptosis in Cisplatin-Induced AKI", J Am Soc Nephrol, 26, pp.2647~2658 (2015)
- Lim SW, "Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury", Lab Invest, 95, pp.1174~1185 (2015)
- Katagiri D, "Protection of glucagon-like peptide-1 in cisplatin-induced renal injury elucidates gut-kidney connection", J Am Soc Nephrol, 24, pp.2034~2043 (2013)
- Smiałowska M, "Neuroprotective effects of neuropeptide Y-Y2, Y5 receptor agonists in vitro, in vivo", Neuropeptides, 43, pp.235~249 (2009)
- Wei Q, "The pathological role of Bax in cisplatin nephrotoxicity", Kidney Int, 72, pp.53~62 (2007)
- 황현숙, "PEP-1-FK506BP12 inhibits matrix metalloproteinase expression in human articular chondrocytes and in a mouse carrageenan-induced arthritis model", BMB Reports, 48(7), pp.407~412 (2015), 생화학분자생물학회
- Lifang Hu, "Knockdown of microtubule actin crosslinking factor 1 inhibits cell proliferation in MC3T3-E1 osteoblastic cells", BMB Reports, 48(10), pp.583~588 (2015), 생화학분자생물학회